CClinicalTrials.gg
Status unknownNCT02989116APEXUpdated Dec 12, 2016

Executive Training and Brain in Children

An interventional study of Inhibition training and Working memory training in Healthy Children and Preterm Birth, sponsored by University Hospital, Caen. Status unknown at 1 site in France. Open to participants aged 9 Years to 10 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-12-12.

Sponsored by University Hospital, Caen · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified Nov 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Non-randomized
Ages
9 Years to 10 Years
Sex
All
01

Study summary

The purpose of this study is to determine whether a daily executive training to cognitive inhibition, working memory or mindfulness as compared to an active control condition has a near- and far-transfer impact on brain and behavioral measures as collected in children aged 9-10 years, either born preterm or full-term.

02

Conditions studied

  • Healthy Children
  • Preterm Birth

Browse trials for

Keywords

  • Learning
  • Executive functions
  • Cognitive control
  • Prefrontal Cortex
  • Typically developing children
  • Genotype
  • Functional Magnetic Resonance Imaging
  • Structural Magnetic Resonance Imaging
  • Inhibition
  • Working Memory
  • Metacognition
  • Mindfulness
  • Preterm children
  • Developmental Psychology
  • Developmental cognitive neuroscience
  • Touch screen tablet
  • Adaptive training
03

In context

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 500 are open to participants now.

This study's planned enrollment of 150 is above the median of 84 across 1,691 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

University Hospital, Caen is the lead sponsor of 505 studies on the registry; 80 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria for all children:

  • Male or female
  • Aged 9-10 years at inclusion
  • French school curriculum (since 1st grade)
  • Fully informed through the dedicated booklet
  • Both parents gave their written consent
  • Normal medical, neurological and brain imaging assessment

Inclusion criterion for non preterm children only:

  • Full term pregnancy with no abnormal event (>= 37 weeks of amenorrhea)

Inclusion criterion for preterm children only:

  • Delivery before 33 weeks of amenorrhea

Exclusion Criteria for all participants:

  • Age over or under 9-10 years old at inclusion
  • Monozygotic twins
  • Restrictions to a Magnetic Resonance brain imaging exam: claustrophobia, metallic elements (cardiac implants, cochlear implants, metallic elements in the brain or the eyes and being close to the nervous system, metallic prothesis, braces), restless participants.
  • Sudden cognitive impairments due to a stroke, head injury associated with loss of consciousness for more than one hour or encephalitis.
  • Chronic neurological, psychiatric, infectious or liver condition, endocrine disruption.
  • Past or current medical condition: cancer, diabetes, chronic lung condition, cardiac, metabolic, hematological, endocrine or immunological disorder.
  • Medication assumed to interfere with brain imaging measures (psychotropics, hypnotics, anxiolytics, neuroleptics, benzodiazepine, steroidal anti-inflammatory, anti-epileptics, painkillers, muscle relaxants).
  • Left-sided handedness
  • Colour blindness or non-corrected visual disturbances
  • Diagnosed developmental disorders
  • Diagnosed cerebral palsy
  • Diagnosed Fine motor disturbances
  • Parents not affiliated to the Social Security
  • Parents not able to join at each time of the study
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Preterm Inhibition

    In children born very preterm: Inhibition training, Saliva collection, Brain Magnetic Resonance Imaging, Cognitive testing

    Behavioral: Inhibition training · Genetic: Saliva collection · Procedure: Brain Magnetic Resonance Imaging · Behavioral: Cognitive testing

  • Experimental
    Full-term Inhibition

    In children born full-term: Inhibition training, Saliva collection, Brain Magnetic Resonance Imaging, Cognitive testing

    Behavioral: Inhibition training · Genetic: Saliva collection · Procedure: Brain Magnetic Resonance Imaging · Behavioral: Cognitive testing

  • Experimental
    Full-term Working memory

    In children born full-term: Working memory training, Saliva collection, Brain Magnetic Resonance Imaging, Cognitive testing

    Behavioral: Working memory training · Genetic: Saliva collection · Procedure: Brain Magnetic Resonance Imaging · Behavioral: Cognitive testing

  • Experimental
    Full-term Mindfulness

    In children born full-term: Mindfulness training, Saliva collection, Brain Magnetic Resonance Imaging, Cognitive testing

    Behavioral: Mindfulness training · Genetic: Saliva collection · Procedure: Brain Magnetic Resonance Imaging · Behavioral: Cognitive testing

  • Active comparator
    Full-term Active control

    In children born full-term: Active control training, Saliva collection, Brain Magnetic Resonance Imaging, Cognitive testing

    Behavioral: Active control training · Genetic: Saliva collection · Procedure: Brain Magnetic Resonance Imaging · Behavioral: Cognitive testing

Interventions

  • BehavioralInhibition training

    Inhibition training on a tactile tablet for a month (20 sessions of 15 min)

  • BehavioralWorking memory training

    Working memory training on a tactile tablet for a month (20 sessions of 15 min)

  • BehavioralMindfulness training

    Mindfulness training on a tactile tablet for a month (20 sessions of 15 min)

  • BehavioralActive control training

    Active control training on a tactile tablet for a month (20 sessions of 15 min)

  • GeneticSaliva collection

    Collection of a saliva sample for genotyping

  • ProcedureBrain Magnetic Resonance Imaging

    Structural and functional MRI

  • BehavioralCognitive testing

    Battery of cognitive and academic tasks on executive functions

06

What researchers measure

Primary outcomes

  1. Change in brain functional BOLD activity after one month of executive training as assessed by MRI in regions subtending executive functioning.

    Change in brain activation will be measured with functional magnetic resonance imaging (fMRI) during two different tasks: a Stop Signal task assessing inhibition and a Dot task assessing working memory.

    Time frame: 3 months: Pretest (t0), immediate Post-test (t0+1 month), deferred post-test (t0+3 months)

  2. Change in brain cortical structure after one month of executive training as assessed by anatomical MRI in regions subtending executive functioning.

    Change in brain cortical structure will be measured with anatomical magnetic resonance imaging (aMRI) using four different measures: 2.a. grey matter volume 2.b. cortical thickness 2.c. cortical surface area 2.d. curvature

    Time frame: 3 months: Pretest (t0), immediate Post-test (t0+1 month), deferred post-test (t0+3 months)

  3. Change in cognitive behavioral measures after one month of executive training as assessed by cognitive testing

    The cognitive testing session includes several tasks assessing executive functioning under different conditions. Will be investigated: 3.a. Response Time 3.b. Accuracy

    Time frame: 3 months: Pretest (t0), immediate Post-test (t0+1 month), deferred post-test (t0+3 months)

Secondary outcomes

  1. Sulcal morphometry measured by anatomical MRI

    Assessing the impact of the early determined sulcal morphometry on behavioral and brain changes associated to a one-month executive training.

    Time frame: Pretest (t0)

  2. Genetic variations measured by Single Nucleotide Polymorphism (SNP) genotyping

    Assessing the impact of the different genotypes on behavioral and brain changes associated to a one-month executive training.

    Time frame: Pretest (t0)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 12, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02989116
Lead sponsor
University Hospital, Caen
Collaborators
National Research Agency, France
Responsible party
Sponsor
First posted
Dec 12, 2016
Start date
Oct 2015
Primary completion
Oct 2019 (estimated)
Completion
Dec 2019 (estimated)
Last update
Dec 12, 2016

Study contacts

Bernard Guillois, Professor
Contact
guillois-b@chu-caen.fr
02.31.25.27.64 ext. +33
Olivier Houdé, Professor
Contact
olivier.houde@parisdescartes.fr
01.40.46.29.95 ext. +33
Olivier Houdé, Professor
principal investigator · University of Paris 5 - Rene Descartes

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion